BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teh JLF, Purwin TJ, Han A, Chua V, Patel P, Baqai U, Liao C, Bechtel N, Sato T, Davies MA, Aguirre-Ghiso J, Aplin AE. Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma. Mol Cancer Ther 2020;19:1719-26. [PMID: 32430489 DOI: 10.1158/1535-7163.MCT-19-1016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Jour G, Illa-Bochaca I, Ibrahim M, Donnelly D, Zhu K, Vega-Saenz de Miera E, Vasudevaraja V, Mezzano V, Ramswami S, Yeh YH, Winskill C, Betensky RA, Mehnert J, Osman I. Genomic and transcriptomic analyses of NF1-mutant melanoma identify potential targeted approach for treatment. J Invest Dermatol 2022:S0022-202X(22)01780-8. [PMID: 35988589 DOI: 10.1016/j.jid.2022.07.022] [Reference Citation Analysis]
2 Caksa S, Baqai U, Aplin AE. The future of targeted kinase inhibitors in melanoma. Pharmacol Ther 2022;239:108200. [PMID: 35513054 DOI: 10.1016/j.pharmthera.2022.108200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sager RA, Backe SJ, Ahanin E, Smith G, Nsouli I, Woodford MR, Bratslavsky G, Bourboulia D, Mollapour M. Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma. Nat Rev Urol 2022. [PMID: 35264774 DOI: 10.1038/s41585-022-00571-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee HA, Chu KB, Moon EK, Quan FS. Histone Deacetylase Inhibitor-Induced CDKN2B and CDKN2D Contribute to G2/M Cell Cycle Arrest Incurred by Oxidative Stress in Hepatocellular Carcinoma Cells via Forkhead Box M1 Suppression. J Cancer 2021;12:5086-98. [PMID: 34335925 DOI: 10.7150/jca.60027] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Han A, Schug ZT, Aplin AE. Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma. Trends Cancer 2021;7:671-81. [PMID: 34127435 DOI: 10.1016/j.trecan.2021.05.005] [Reference Citation Analysis]
6 Indini A, Grossi F, Mandalà M, Taverna D, Audrito V. Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications. Biomedicines 2021;9:607. [PMID: 34073463 DOI: 10.3390/biomedicines9060607] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang X, Shetty M, Clemente V, Linder S, Bazzaro M. Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries. Int J Mol Sci 2021;22:4750. [PMID: 33947138 DOI: 10.3390/ijms22094750] [Reference Citation Analysis]